Library / Laws / 117th Congress / House Bills / H.R. 6625
H.R. 6625
To prohibit the Secretary of Health and Human Services from issuing guidance intended to restrict access to COVID–19 monoclonal antibody therapies and other treatments.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2022-02-07 | 1.7K | ⠃⠗⠋ |